目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value
3.2. Market volume

4 Market Segmentation
4.1. Geography segmentation

5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Have there been any recent developments in the market?

8 Company Profiles
8.1. Teva Pharmaceutical Industries Ltd
8.2. Novartis AG
8.3. Hikma Pharmaceuticals Plc
8.4. Sanofi
8.5. Sandoz Group AG

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Europe generics market value: $ million, 2018-23
Table 2: Europe generics market volume: % of total pharma volume, 2018-23
Table 3: Europe generics market geography segmentation: $ million, 2023
Table 4: Europe generics market value forecast: $ million, 2023-28
Table 5: Europe generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Teva Pharmaceutical Industries Ltd: Key Facts
Table 7: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Ltd: Key Employees
Table 9: Novartis AG: Key Facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Hikma Pharmaceuticals Plc: Key Facts
Table 13: Hikma Pharmaceuticals Plc: Annual Financial Ratios
Table 14: Hikma Pharmaceuticals Plc: Key Employees
Table 15: Sanofi: Key Facts
Table 16: Sanofi: Annual Financial Ratios
Table 17: Sanofi: Key Employees
Table 18: Sandoz Group AG: Key Facts
Table 19: Sandoz Group AG: Key Employees
Table 20: Europe Size of Population (million), 2019-23
Table 21: Europe real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 22: Europe GDP (Current Prices, $ Billion), 2019-23
Table 23: Europe Inflation, 2019-23
Table 24: Europe Consumer Price Index (Absolute), 2019-23
Table 25: Europe % of total pharma volume-23

List of Figures
Figure 1: Europe generics market value: $ million, 2018-23
Figure 2: Europe generics market volume: % of total pharma volume, 2018-23
Figure 3: Europe generics market geography segmentation: % share, by value, 2023
Figure 4: Europe generics market value forecast: $ million, 2023-28
Figure 5: Europe generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in Europe, 2023
Figure 7: Drivers of buyer power in the generics market in Europe, 2023
Figure 8: Drivers of supplier power in the generics market in Europe, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Europe, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in Europe, 2023
Figure 11: Drivers of degree of rivalry in the generics market in Europe, 2023